Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases (Q36925542)

17 August 2017

1 reference

title

Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases (English)

1 reference

17 August 2017

Eric Dayer

1

1 reference

PubMed ID

17762850

17 August 2017

Jean-Michel Dayer

series ordinal

2

1 reference

PubMed ID

17762850

17 August 2017

Pascale Roux-Lombard

series ordinal

3

1 reference

17 August 2017

1 September 2007

1 reference

Nature Clinical Practice Rheumatology

17 August 2017

1 reference

17 August 2017

3

1 reference

17 August 2017

9

1 reference

17 August 2017

512-520

1 reference

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

17 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

The diagnostic value of the neutrophil left shift in predicting inflammatory and infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

The soluble interleukin 6 receptor: mechanisms of production and implications in disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

C-reactive protein: ligands, receptors and role in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Corticosteroid requirements in polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

C-reactive protein: a critical update

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Limits to the Use of the Procalcitonin Level as a Diagnostic Marker

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

High serum procalcitonin concentrations in patients with sepsis and infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Procalcitonin (PCT) production in a thyroidectomized patient

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

The future diagnostic role of procalcitonin levels: the need for improved sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Changes in procalcitonin and interleukin 6 levels among treated African patients with different clinical forms of malaria.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

CRP levels in autoimmune disease can be specified by measurement of procalcitonin

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-κB–dependent signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Diagnosis and management of adult onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

High-density lipoprotein function recent advances

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Acute inflammatory state during influenza infection and endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Familial autoinflammatory diseases: genetics, pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Blocking IL-1 in systemic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Deficiency in systemic interleukin-1 receptor antagonist production as an operative risk factor in malnourished elderly patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Biochemical markers in osteoarthritis: will they measure up?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Proteomic biomarkers for autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0572

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0572

1 reference

17 August 2017

1 reference

PubMed ID

17762850